TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 1 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $11,000 | 0.0% | 50,239 | -4.6% | 0.00% | – |
Q3 2018 | $11,000 | -80.7% | 52,639 | 0.0% | 0.00% | – |
Q2 2018 | $57,000 | +3.6% | 52,639 | 0.0% | 0.00% | – |
Q1 2018 | $55,000 | -22.5% | 52,639 | -0.6% | 0.00% | – |
Q4 2017 | $71,000 | -15.5% | 52,939 | +10.3% | 0.00% | – |
Q3 2017 | $84,000 | -8.7% | 47,998 | -0.4% | 0.00% | – |
Q2 2017 | $92,000 | -86.4% | 48,198 | -76.5% | 0.00% | – |
Q1 2017 | $678,000 | -13.2% | 205,367 | +5.2% | 0.00% | – |
Q4 2016 | $781,000 | -33.6% | 195,263 | -2.4% | 0.00% | – |
Q3 2016 | $1,177,000 | +12.0% | 200,132 | +4.1% | 0.00% | – |
Q2 2016 | $1,051,000 | +821.9% | 192,169 | +706.8% | 0.00% | – |
Q1 2016 | $114,000 | +65.2% | 23,819 | +53.0% | 0.00% | – |
Q4 2015 | $69,000 | – | 15,573 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 1,200,000 | $249,000 | 0.15% |
SABBY MANAGEMENT, LLC | 1,518,294 | $314,000 | 0.04% |
Cornerstone Wealth Management, LLC | 2,400 | $1,000,000 | 0.01% |
ARMISTICE CAPITAL, LLC | 220,000 | $46,000 | 0.00% |
Ballew Advisors, Inc | 4,000 | $1,000 | 0.00% |
Blume Capital Management, Inc. | 2,546 | $1,000 | 0.00% |
Cutter & CO Brokerage, Inc. | 10,000 | $2,000 | 0.00% |
UBS Group AG | 5,316 | $1,000 | 0.00% |
Stratos Wealth Partners, LTD. | 1,500 | $0 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 2,820 | $0 | 0.00% |